Should any genetic defect affecting α-granules in platelets be classified as gray platelet syndrome?

American Journal of Hematology

Volumn 91, Issue 7, 2016, Pages 714-718

  Nurden, Alan T ^a   Nurden, Paquita ^a  

^a Ctr Geriatrie Ctr Hosp Univ B   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GRANULE PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ARTHROGRYPOSIS RENAL DYSFUNCTION CHOLESTASIS SYNDROME; GATA1 GENE; GENE; GENE MUTATION; GENETIC DISORDER; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GFI1B GENE; GRAY PLATELET SYNDROME; HEMOSTASIS; HUMAN; NBEAL2 GENE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; REVIEW; SYNDROME; THROMBOCYTE; THROMBOCYTE PRESERVATION; VIPAS39 GENE; VPS33B GENE;

EID: 84973879552     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24359     Document Type: Review

References (38)

1. Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011;105(Suppl 1):S13–S33.
2. Burkhart JM, Gambaryan S, Watson SP, et al. What can proteomics tell us about platelets? Circ Res 2014;114:1204–1219.
3. Nurden AT, Nurden P. Inherited disorders of platelet function: Selected updates. J Thromb Haemost 2015;S2–S9.
4. Raccuglia G. Gray platelet syndrome. A variety of qualitative platelet disorder. Am J Med 1971;51:818–828.
5. Gunay-Aygun M, Zivony-Elboum Y, Gumruk F, et al. Gray platelet syndrome: Natural history of a large patient cohort and locus assignment to chromosome 3p. Blood 2010;116:4990–5001.
6. Favier R, Raslova H. Progress in understanding the diagnosis and molecular genetics of macrothrombocytopenias. Br J Haematol 2015;170:626–639.
7. Larocca LM, Heller PG, Podda G, et al. Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome. Platelets 2015;26:751–757.
8. Nurden AT, Nurden P. The gray platelet syndrome: Clinical spectrum of the disease. Blood Rev 2007;21:21–36.
9. Sakurai Y, Fitch-Tewflik JL, Ahn B, et al. Platelet geometry sensing spatially regulates α-granule secretion to enable matrix self-deposition. Blood 2015;126:531–538.
10. Albers CA, Cvejic A, Favier R, et al. Exome sequencing identifies NBEAL2 as the causative gene for gray platelet syndrome. Nat Genet 2011;43:735–737.
11. Gunay-Aygun M, Falik-Zaccai TC, Vilboux T, et al. NBEAL2 is mutated in gray platelet syndrome and is required for biogenesis of platelet α-granules. Nat Genet 2011;43:732–734.
12. Kahr WHA, Hinckley J, Li L, et al. Mutations in NBEAL2, encoding a BEACH protein, cause gray platelet syndrome. Nat Genet 2011;43:738–740.
13. Bottega R, Pecci A, De Candia E, et al. Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency. Haematologica 2013;98:868–874.
14. Cullinane AR, Schäffer AA, Huizing M. The BEACH is hot: A LYST of emerging roles for BEACH-domain containing proteins in human disease. Traffic 2013;14:749–766.
15. Deppermann C, Cherpokova D, Nurden P, et al. Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice. J Clin Invest 2013;123:3331–3342.
16. Kahr WH, Lo RW, Li L, et al. Abnormal megakaryocyte development and platelet function in Nbeal2(-/-) mice. Blood 2013;122:3349–3358.
17. Guerrero JA, Bennett C, van der Weyden L, et al. Gray platelet syndrome: Proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice. Blood 2014;124:3624–3635.
18. Rensing-Ehl A, Pannicke U, Zimmermann S-Y, et al. Gray platelet syndrome can mimic autoimmune lymphoproliferative syndrome. Blood 2015;126:1967–1969.
19. Drouin A, Favier R, Massé JM, et al. Newly recognized cellular abnormalities in the gray platelet syndrome. Blood 2001;98:1382–1391.
20. Smith H, Galmes R, Gogolina E, et al. Associations among genotype, clinical phenotype, and intracellular localization of trafficking proteins in ARC syndrome. Hum Mutat 2012;33:1656–1664.
21. Bem D, Smith H, Banushi B, et al. VPS33B regulates protein sorting into and maturation of α-granule progenitor organelles in mouse megakaryocytes. Blood 2015;126:133–143.
22. Saleque S, Cameron S, Orkin SH. The zinc-finger proto-oncogene Gfi-1b is essential for development of the erythroid and megakaryocytic lineages. Genes Dev 2002;16:301–306.
23. Khandapour C, Sharif-Askari E, Vassen L, et al. Evidence that Growth factor independence 1B regulates dormancy and peripheral blood mobilization of hematopoietic stem cells. Blood 2010;116:5149–5161.
24. Foudi A, Kramer DJ, Qin J, et al. Distinct requirements for Gfi-1b in adult bone marrow red cell and platelet generation. J Exp Med 2014;211:909–927.
25. Möröy T, Vassen L, Wilkes B, Khandanpour C. From cytopenia to leukemia: The role of Gfi1 and Gfi1b in blood formation. Blood 2015;126:2561–2569.
26. Chen L, Kostadima M, Martens JHA, et al. Transcriptional diversity during lineage commitment of human blood progenitors. Science 2014;345:6304.
27. Stevenson WS, Morel-Kopp M-C, Chen Q, et al. GFI1B causes a bleeding disorder with abnormal platelet function. J Thromb Haemost 2013;11:2039–2047.
28. Monteferrario D, Bolar NA, Marneth AE, et al. A dominant-negative GFI1B mutation in the gray platelet syndrome. N Engl J Med 2014;370:245–253.
29. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4:1073–1081.
30. Kunishima S, Okuno Y, Yoshida K, et al. ACTN1 mutations cause congenital macrothrombocytopenia. Am J Hum Genet 2013;93:431–438.
31. Sengupta A, Upadhyay G, Sen S, Saleque S. Reciprocal regulation of alternative lineages by Rgs18 and its transcriptional repressor Gfi1b. J Cell Sci 2016;129:145–154.
32. Tubman V, Levine JE, Campagna DR, et al. X-linked gray platelet syndrome due to a GATA/Arg216Gln mutation. Blood 2007;109:3297–3299.
33. Balduini CL, Pecci A, Loffredo G, et al. Effects of the R216Q mutation of GATA-1 on erythropoiesis and megakaryocytopoiesis. Thromb Haemost 2004;91:129–140.
34. Hughan SC, Senis Y, Best D, et al. Selective impairment of platelet activation to collagen in the absence of GATA1. Blood 2005;105:4369–4376.
35. Koseoglu S, Flaumenhaft T. Advances in platelet granule biology. Curr Opin Hematol 2013;20:464–471.
36. Heijnen H, van der Sluijs P. Platelet secretory behavior: As diverse as the granules…or not? J Thromb Haemost 2015;13:2141–2151.
37. Peters GC, Michelson AD, Flaumenhaft R. Granule exocytosis is required for platelet spreading: Differential sorting of α-granules expressing VAMP-7. Blood 2012;120:199–206.
38. Stevenson WS, Morel-Kopp MC, Ward CM. Platelets are not all gray in GFI1B disease. Clin Genet 2015;87:299.